We also found that the expression levels of TIGIT on CD8 + T cells, CD4 + T cells and NK cells in TILs and TDLNs treated with RT were statistically significantly higher than expression levels on cells not treated with RT in LLC and B16 tumor-bearing mouse models. The gene discussed is CD4; the disease is neoplasm.